101 Therapeutics

About:

101 Therapeutics is a clinical stage pharma company curing infectious diseases by targeting the pathology not the the pathogen.

Website: https://101therapeutics.com

Twitter/X: 101therapeutics

Top Investors: Awz Ventures

Description:

101 Therapeutics is a Phase II pharmaceutical company on a mission to cure infectious diseases by targeting the pathology not the the pathogen. After a successful Phase I safety trial, 101 Therapeutics is conducting a Phase II efficacy trials for its targeted COVID-19 therapy.

Total Funding Amount:

$15M

Headquarters Location:

Tel Aviv, Tel Aviv, Israel

Founded Date:

2020-01-01

Contact Email:

info(AT)101therapeutics.com

Founders:

Alec Goldberg, James Goldberg

Number of Employees:

1-10

Last Funding Date:

2022-10-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai